1 / 20

Update Report on the activity of the HMA Task Force on R esources for MRP and DCP

Update Report on the activity of the HMA Task Force on R esources for MRP and DCP C hrister Backman. Based on: M eeting of the HM A Task Force on R esources for MRP and DCP Uppsala , S weden 23 March , 201 1 New chair Christina Åkerman, Sweden.

lydia
Download Presentation

Update Report on the activity of the HMA Task Force on R esources for MRP and DCP

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Update Report on the activity of the HMA Task Force on Resources for MRP and DCP Christer Backman

  2. Based on: • Meeting of the HMA Task Force on Resourcesfor MRP and DCP • Uppsala, Sweden • 23 March, 2011 • New chair • Christina Åkerman, Sweden

  3. Main items on TF Agenda – 23 March 2011 • Contribution to implementation of HMA Strategy 2011-2015 • Ad hoc group on ASMF – separate presentation by Christa Wirthumer Hoche • Validation issues • National requirements • Clock stops

  4. Main items on TF Agenda – 23 March 2011 • Time for issuing MAs • Assessement report feedback forms • More areas for worksharing • Transparency of slot oppurtunities • Follow up with industry

  5. Contribution to implementation of HMA Strategy 2011-2015 • (37) Optimum utilization of resources, including financial, 5.64, 5.65 • Report on task force on resources in MRP/DCP • Working Group of Quality Managers

  6. Contribution to implementation of HMA Strategy 2011-2015 • (38) Making decentralized processes work better, 5.66, 5.67 • Coordinated Group for MRP and DCP (V+H) • Working Group of Quality Managers • Task Force on Resources in DCP and • WP on Future of CMDh

  7. Contribution to implementation of HMA Strategy 2011-2015 • (39) Extending new EU variation regulation provisions to national variations, 5.66 • Coordinated Group for MRP and DCP(V+H) • Working Group of Quality Managers • Task Force on Resources in DCP

  8. Contribution to implementation of HMA Strategy 2011-2015 • (40) Supporting new functionality bestowed on CMD-h by strengthened pharmacovigilance legislation, 5.66 • Coordinated Group for MRP and DCP • Task Force on Resources in DCP • Proposal – Best Practice session in HMA Nov 2011 on the need of national resources for the new PhVig tasks

  9. Contribution to implementation of HMA Strategy 2011-2015 • (41) Providing more authorized medicines for children and implementation of paediatric regulation provisions, 5.66 • Coordinated Group for MRP and DCP • Task Force on Resources in DCP

  10. Contribution to implementation of HMA Strategy 2011-2015 • (42) Promoting work sharing and principle of fair distribution of work across the Network, 5.68 • Coordinated Group for MRP and DCP (V+H) • Task Force on Resources in DCP

  11. Validation issues • Templates are being used • Still issues both from MSs and MAHs • Need more discussions in CMDh • Eudralink need improvement – TSG - TMC

  12. Electronic validation • still problems with disharmonised technical validation • depending both on different validation tools and different handling by MSs • TIGes has adopted new technical validation criteria for eCTD and NeeS to be used by all NCAs by September 2011 • Training/workshop is planned for all MSs at EMA in time before September • The technical validation process also have to be better defined; proposal that RMS do the technical validation on behalf of all CMS in DCP and MRP • Important that: • HMA endorse the use of the harmonised validation criteria (no other national) • HMA send a representative to the validation workshop ( reimbursed by EMA) • HMA endorse the idea of RMS to do technical validation and in their agencies secure the tools (free of charge) and skills for it

  13. Clock stops • More follow up • Need better statistics

  14. National phase • EGA results of survey based on 2864 national procedures finalized in 2009 and 2010. • Great variance by country for MA grant times. • According to EGA 12 MS are showing a tendency or slight tendency to decrease average MA grant times between 2009 and 2010. • For other MSs, there was either no trend to decrease or large variability so no overall conclusion could be drawn.

  15. National phase • Issue a MA with product information in English (SE model) • legal aspects in MS? • Do we have national requirements after the end of the procedure for issuing a MA ? • updated application form (in national language) • special forms/declarations to be filled in • submission of ‘artwork’ • reimbursement questions (including slot requests)

  16. Assessment Report feedback form • Aim: • To reach more consistency in preparing Assessment Reports; • To reduce Parallel Assessment; • To facilitate mutual recognition; • To identify areas for improvement (recommendations, training, …) • Decided to have a report to HMA in July in order to evaluate in November

  17. More areas for worksharing? Formal work sharing procedures • PSURs • Paediatrics • Variations • PMFs • Others? Informal work sharing procedures • Sharing of assessment reports for ongoing and approved national (including DCP/MRP) procedures • Ad-hoc work sharing arranged at level of CMD eg shortage of radiopharmaceuticals More brainstorming needed

  18. Transparency of slot opportunities • Already transparent but……. • Closer monitoring, update of information • Is there really a problem……. • Cancellation of slots – 30-50 %

  19. Follow up with industry • CMDh already do • WP on Future plan to do • Proposal • For HMA TF on resources – use HMA stakeholders meetings!

  20. Next steps • Await guidance from HMA strategy lead (Gro) • Report on progress to HMA in July

More Related